Company Updates
Investors Can Now Receive 20% Tax Offset on Their Investments
The upcoming ESIC Tax Offset deadlines, as recent media indicates that more attention is needed on this new incentive.
Actinogen Medical Presenting at the BIO International Conversation in San Diego
Actinogen Medical (ASX: ACW) is pleased to announce that the Company‘s CEO, Dr. Bill Ketelbey, is leading the Actinogen team and presenting at the BIO International Convention in San Diego.
Intermin Resources Limited Self-Funds Its Exploration
Intermin Resources Ltd (IRC) intends to self-fund its exploration through the development of a number of small mining projects in the Kalgoorlie to Menzies region of WA’s Eastern Goldfields.
AsiaPhos Undertakes Internal Restructuring to Expand Downstream Chemical Business
AsiaPhos Limited, a Singapore-headquartered mineral resources company focused on exploring and mining phosphate with a vertically-integrated business model.
Antisense Therapeutics Reports Positive Effects Seen with ALT1102 for MS
Antisense Therapeutics reports that an analysis of brain lesion data from the Phase II study of the ATL1102 in patients with Multiple Sclerosis (MS).
Intermin Strong Cashflow Being Generated at the Teal Gold Mine
Intermin Resources Limited (ASX: IRC) is pleased to provide an operational update from Intermin’s 100% owned Teal Gold Mine, located 11km north west of Kalgoorlie-Boulder in Western Australia.
Moneyball Celebrates 160,000+ Members & 50% YoY Revenue Growth as its Capital Raise Reaches 75%
Moneyball has continued to enjoy outstanding growth in recent months, remaining Australia’s largest Daily Fantasy Sports (DFS) platform and India’s number 2 DFS platform.
Suitebox Partners with Centrepoint Alliance to Deliver Virtual Workspaces to Financial Advisers
Through integration with Suitebox, advisers will enjoy video conferencing and digital document signing as well as highly secure cloud storage.
Proteomics International Laboratories Clinical Validation Study Confirms PromarkerD Performance
Proteomics International Laboratories Ltd (ASX: PIQ) (PILL) announced results from its validation clinical study showing that PromarkerD blood test can predict the onset of diabetic kidney disease.
Backed By Leading Investment Groups and Family Offices
